Leah Marie Provost, RN | |
224 Malbons Mills Rd, Skowhegan, ME 04976-4137 | |
(207) 431-8259 | |
Not Available |
Full Name | Leah Marie Provost |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 224 Malbons Mills Rd, Skowhegan, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184403958 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | RN56408 (Maine) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Leah Marie Provost, RN 224 Malbons Mills Rd, Skowhegan, ME 04976-4137 Ph: (207) 431-8259 | Leah Marie Provost, RN 224 Malbons Mills Rd, Skowhegan, ME 04976-4137 Ph: (207) 431-8259 |
News Archive
Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today announced achievement of a US$4.0 million milestone payment from its development partner, Endo Pharmaceuticals Inc. This milestone is the fourth achieved by Bioniche subsequent to the parties executing their agreement in July, 2009.
The Pediatric Heart Center at Tulane Hospital for Children has opened the first and only Hybrid Cath Lab in Louisiana. The cutting-edge facility - one of only 10 in the country - is a fully equipped pediatric catheterization lab and operating room that allows both cardiologists and surgeons to work side by side to open the chest, place delivery catheters in the heart and deploy devices. Outcomes are improved by avoiding cardiopulmonary bypass and shortened procedure times.
It may have taken 12 years, but researchers now say that studies involving nearly 40,000 women in the U.S. has found that regular, low doses of aspirin do not prevent cancer, and vitamin E is pretty ineffective in warding off both heart disease and cancer.
The development of simple tests to predict a leukemic relapse in young patients is a step closer thanks to researchers from the Sainte-Justine University Hospital Research Center and the University of Montreal. Approximately 20 percent of young leukemia patients who are treated with stem cells derived from umbilical cord blood will experience leukemic relapse.
Aggressive forms of breast cancer often manipulate the immune response in their favor. This manipulation is revealed in humans by the same immunological "signature" as in mice. This is shown by a study carried out by scientists from the University of Bonn together with Dutch colleagues.
› Verified 3 days ago